Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Receivables (2018 - 2025)

TELA Bio (TELA) has 8 years of Change in Receivables data on record, last reported at $107000.0 in Q3 2025.

  • For Q3 2025, Change in Receivables fell 94.67% year-over-year to $107000.0; the TTM value through Sep 2025 reached $59000.0, down 98.24%, while the annual FY2024 figure was $762000.0, 75.08% down from the prior year.
  • Change in Receivables reached $107000.0 in Q3 2025 per TELA's latest filing, down from $533000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $2.0 million in Q3 2024 and bottomed at -$983000.0 in Q4 2024.
  • Average Change in Receivables over 5 years is $465052.6, with a median of $402000.0 recorded in 2025.
  • Peak YoY movement for Change in Receivables: skyrocketed 1502.44% in 2021, then tumbled 161.36% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $657000.0 in 2021, then surged by 35.46% to $890000.0 in 2022, then skyrocketed by 80.0% to $1.6 million in 2023, then crashed by 161.36% to -$983000.0 in 2024, then skyrocketed by 110.89% to $107000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $107000.0 in Q3 2025, $533000.0 in Q2 2025, and $402000.0 in Q1 2025.